Vanguard Fiduciary Trust
TNYA icon

Vanguard Fiduciary Trust’s Tenaya Therapeutics TNYA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$730K Sell
987,505
-28,197
-3% -$21.4K ﹤0.01% 3143
2026
Q1 		$703K Buy
+1,015,702
New +$750K ﹤0.01% 3081

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust's TNYA Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Tenaya Therapeutics (TNYA) stake by 2.8% in Q2 2026, selling an estimated $21.4K and leaving 987,505 shares worth $730K. The position accounts for ﹤0.01% of the portfolio, ranked #3143.

Vanguard Fiduciary Trust first reported a position in TNYA in Q1 2026 and has held it in 2 quarters since. 102 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Vanguard Fiduciary Trust held 987,505 shares of Tenaya Therapeutics worth $730K as of Q2 2026.
  • Vanguard Fiduciary Trust sold 28,197 Tenaya Therapeutics shares in Q2 2026, an estimated $21.4K.
  • Tenaya Therapeutics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3143 holding.
  • Vanguard Fiduciary Trust first reported a position in Tenaya Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 102 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.